Dimensia - What Are the Ethical Considerations When Choosing to Prescribe?

Aducanamab may be the first of tentially many other drugs to come to market indicated for disease modification of a ner degenerative disease. In most cases, decisions about these treatments will be made with patients who still have capacity. Anamab is a very stark illustration of those disparities and something that our field really needs to address going forward.